HomeInvestorsProfile

ClavystBio

We are on a mission to accelerate life science breakthroughs into health impact 


Location

Industry

Company Size

11 - 50 employees

Year Founded

2022

Verified Investor

Yes

Investment Sectors

Lead Investor

No


About ClavystBio

ClavystBio invests and partners with innovators, entrepreneurs, and founders to launch and grow global companies from Singapore.

ClavystBio is a life sciences investor and venture builder set up by Temasek to accelerate the commercialization of breakthrough ideas into health impact. ClavystBio invests and partners with innovators, entrepreneurs, and founders, and fosters private and public partnerships, to launch and grow global companies from Singapore. Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics, and digital health companies, as well as early-stage VC funds.

Share This Profile

More Companies

Quantum Ventures

We Back Innovators Addressing Climate Challenges With Capital, Network, & Synergies

Taronga Ventures

Investing globally in real assets, innovation and technology companies to drive change in the built environment

Red Building Capital

Leading Blockchain VC - Bridging Reality with Digital Value, We Build a Better Future!

Choco Up

Asia’s largest revenue-based financing platform, offering funding and growth solutions to digital merchants.

Trihill Capital

Investing in Changemakers Today. Supporting Industry Leaders Tomorrow

Integra Partners

An early stage venture capital firm that invests from Series Pre-A to B across large themes in Southeast Asia. arrow

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.